Search Results for citation:"90 FR 16554"

Found 2 results
Skip to main content

Search Results: citation:"90 FR 16554"

  • Type:Notice
    Citation:90 FR 16554
    Reading Time:about a minute or two

    Patheon API Services Inc. has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of certain controlled substances. This registration is intended to support the clinical trials of their customers. Interested parties are invited to submit comments or objections electronically through the Federal eRulemaking Portal by June 17, 2025. They may also request a hearing on the application by the same date.

    Simple Explanation

    Patheon API Services Inc. wants to make some special medicines and needs permission from a government group called the DEA. People can say what they think about this or ask for a meeting about it before June 17, 2025.

  • Type:Notice
    Citation:90 FR 16554
    Reading Time:about a minute or two

    Scottsdale Research Institute has applied to the Drug Enforcement Administration to become an importer of basic classes of controlled substances for clinical research. Specifically, they plan to bring in synthetic cannabidiol for use by Schedule I researchers. People interested in this application can submit comments or request a hearing by May 19, 2025. The application does not include permission for importing substances for commercial sale.

    Simple Explanation

    Scottsdale Research Institute wants permission from the government to bring in special medicine from other countries to study it in research projects, but they can't sell it. People can say what they think about this plan until May 19, 2025.